<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Neurology Briefing - James Saint</title>
    <style>
        body {
            background-color: #EEE;
            font-family: 'Titillium Web', sans-serif;
            color: #222;
            margin: 2rem;
            line-height: 1.6;
        }
        .container {
            max-width: 900px;
            margin: 0 auto;
            padding: 2rem;
            background: #fff;
            border: 1px solid #ccc;
            border-radius: 8px;
        }
        h1, h2 {
            color: #003366;
        }
        ul {
            padding-left: 1.5rem;
        }
        .section {
            margin-bottom: 2rem;
        }
        .tag {
            background-color: #003366;
            color: #FFD700;
            padding: 0.25em 0.75em;
            display: inline-block;
            border-radius: 4px;
            font-weight: bold;
            margin-bottom: 1rem;
        }
    </style>
</head>
<body>
<div class="container">
    <h1>Neurology Briefing: James Saint</h1>
    <p><strong>Date:</strong> May 16, 2025</p>

    <div class="section">
        <div class="tag">Presenting Symptoms</div>
        <ul>
            <li>Progressive left-sided numbness and nerve pain (months-long)</li>
            <li>Intermittent visual disturbances</li>
            <li>Ear pressure (left side)</li>
            <li>Significant fatigue, cognitive fog, sensitivity to heat</li>
            <li>Emotional dysregulation, isolation, agoraphobia (post-onset)</li>
        </ul>
    </div>

    <div class="section">
        <div class="tag">Relevant History</div>
        <ul>
            <li>Received AstraZeneca COVID-19 vaccine (Batch: PW40008 & PZ46990)</li>
            <li>Initial symptoms emerged post-vaccination, worsened over time</li>
            <li>Delayed referral and diagnostic testing despite ongoing symptoms</li>
            <li>Currently under medical investigation with neurology appointment set for 3 June 2025</li>
        </ul>
    </div>

    <div class="section">
        <div class="tag">Suspected Diagnoses</div>
        <ul>
            <li><strong>Primary Likelihood:</strong> Post-vaccine immune-mediated myelitis (60–70%)</li>
            <li><strong>Alternative Possibility:</strong> Primary Progressive Multiple Sclerosis (PPMS) (30–40%)</li>
            <li><strong>Other Differentials:</strong> MOGAD, NMO-Spectrum Disorder, B12/copper deficiency, small vessel ischemic changes</li>
        </ul>
    </div>

    <div class="section">
        <div class="tag">Recommended Diagnostic Actions</div>
        <ul>
            <li>MRI of brain and full spine with contrast</li>
            <li>Lumbar puncture for oligoclonal bands and CSF analysis</li>
            <li>Bloods: ANA, ENA, B12, folate, copper, MOG-IgG, AQP4-IgG, ESR, CRP</li>
            <li>Visual Evoked Potentials (VEP) and nerve conduction testing</li>
        </ul>
    </div>

    <div class="section">
        <div class="tag">Prepared By</div>
        <p>James Saint, patient and system advocate — requesting comprehensive investigation of suspected demyelinating or inflammatory CNS disorder following vaccine-related immune disruption.</p>
    </div>

<div class="section">
    <div class="tag">Symptom Timeline</div>
    <ul>
        <li><strong>2021:</strong> Initial post-vaccine adverse response. Symptoms dismissed by GP.</li>
        <li><strong>2022–2024:</strong> Ongoing fatigue, episodic nerve pain, emotional dysregulation.</li>
        <li><strong>Early 2025:</strong> Clear left-sided neurological symptoms (numbness, pain, ear pressure, vision changes) become progressively worse.</li>
        <li><strong>May 2025:</strong> Bloods taken; neurology referral secured.</li>
        <li><strong>3 June 2025:</strong> Neurology appointment scheduled (MRI and testing expected).</li>
    </ul>
</div>

<div class="section">
    <div class="tag">Neurology Appointment: Suggested Questions</div>
    <ul>
        <li>Can you rule out or confirm a diagnosis of myelitis, MS, or related demyelinating condition?</li>
        <li>Will you be ordering an MRI of both brain and spine — with contrast?</li>
        <li>Can I be tested for MOG and AQP4 antibodies (MOGAD/NMO spectrum)?</li>
        <li>Is a lumbar puncture appropriate at this stage for CSF analysis?</li>
        <li>Should we run a full autoimmune and nutritional deficiency panel (e.g., B12, copper)?</li>
        <li>If it is post-vaccine myelitis, what treatment options and long-term outlook should I prepare for?</li>
        <li>Could this be Primary Progressive MS — and if so, what criteria and follow-up are needed?</li>
        <li>Can we track disease progression over time with regular imaging and blood markers?</li>
        <li>Will I have access to a dedicated MS or neuroinflammatory specialist?</li>
        <li>Can I be referred for rehabilitation or symptom management support while we await diagnosis?</li>
    </ul>
</div>
</div>
</body>
</html>
